A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
This study will investigate participant satisfaction (including compliance, preference,
tolerability) with once-monthly Bonviva in women with post-menopausal osteoporosis or
osteopenia transitioned from once-weekly alendronate or risedronate. The anticipated time on
study treatment is 6 months, and the target sample size is 1776 individuals.